Ustekinumab safe but may reactivate hepatitis B
Clinical study
First Online:
- 21 Downloads
Reference
- Ting SW, et al. Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab. Clinical Drug Investigation : 2 Jul 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0671-z
Copyright information
© Springer Nature Switzerland AG 2018